|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Oculus Innovative Sciences, Inc. (OCLS) Microcyn(R) Technology to be Showcased at the Columbia University 10th Annual Innovations in Complex Vascular & Endovascular Interventions in New York City on May 10-11, 2012
5/9/2012 9:48:21 AM
PETALUMA, Calif., May 9, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a commercial healthcare company that designs, produces and markets innovative, safe and effective healthcare products in multiple markets, announced the company would be exhibiting its Microcyn®-based products at Columbia University's 10th Annual Innovations in Complex Vascular & Endovascular Interventions in New York City, May 10-11, 2012. The two-day educational conference for clinicians will focus on complex arterial and venous vascular procedures, including management options for non-healing wounds and advances in podiatric wound management.
|
|
|
|
|
|
|
|
|
|
|